Abstract:Background: Differentiated thyroid cancer (DTC) is the most common type of thyroid cancer. Many of them can relapse to dedifferentiated thyroid cancer (DDTC) and exhibit different gene expression profiles. The underlying mechanism of dedifferentiation and the involved genes or pathways remained to be investigated. Methods: A discovery cohort obtained from patients who received surgical resection in the Fudan University Shanghai Cancer Center (FUSCC) and two validation cohorts derived from Gene Expression Omnibus (GEO) database were used to screen out differentially expressed genes in the dedifferentiation process. Weighted gene co-expression network analysis (WGCNA) was constructed to identify modules highly related to differentiation. Gene Set Enrichment Analysis (GSEA) was used to identify pathways related to differentiation, and all differentially expressed genes were grouped by function based on the GSEA and literature reviewing data. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to control the number of variables in each group. Next, we used logistic regression to build a gene signature in each group to indicate differentiation status, and we computed receiver operating characteristic (ROC) curve to evaluate the indicative performance of each signature. Results: A total of 307 upregulated and 313 downregulated genes in poorly differentiated thyroid cancer (PDTC) compared with papillary thyroid cancer (PTC) and normal thyroid (NT) were screened out in FUSCC cohort and validated in two GEO cohorts. WGCNA of 620 differential genes yielded the seven core genes with the highest correlation with thyroid differentiation score (TDS). Furthermore, 395 genes significantly correlated with TDS in univariate logistic regression analysis were divided into 11 groups. The areas under the ROC curve (AUCs) of the gene signature of group transcription and epigenetic modification, signal and substance transport, extracellular matrix (ECM), and metabolism in the training set [The Cancer Genome Atlas (TCGA) cohort] and validation set (combined GEO cohort) were both >0.75. The gene signature based on group transcription and epigenetic modification, cilia formation and movement, and proliferation can reflect the patient's disease recurrence state. Conclusion: The dedifferentiation of DTC is affected by a variety of mechanisms including many genes. The gene signature of group transcription and epigenetic modification, signal and substance transport, ECM, and metabolism can be used as biomarkers for DDTC.

A 4 Gene-Based Immune Signature Predicts Dedifferentiation And Immune Exhaustion In Thyroid Cancer

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma

Identification of an immune-related signature indicating the dedifferentiation of thyroid cells

An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors

Identification of Key Functional Gene Signatures Indicative of Dedifferentiation in Papillary Thyroid Cancer

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma

Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment

Identification of Immune-Related Gene Signature for Non-Small Cell Lung Cancer Patients with Immune Checkpoint Inhibitors

Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.

Transcriptome Analyses Identify A Metabolic Gene Signature Indicative Of Dedifferentiation Of Papillary Thyroid Cancer

Novel T cell exhaustion gene signature to predict prognosis and immunotherapy response in thyroid carcinoma from integrated RNA-sequencing analysis

Integrative analysis of key candidate genes and signaling pathways in autoimmune thyroid dysfunction related to anti-CTLA-4 therapy by bioinformatics

Development and Validation of an Inflammatory Response-Related Signature in Triple Negative Breast Cancer for Predicting Prognosis and Immunotherapy

Identification of signature genes and immune infiltration analysis in thyroid cancer based on PANoptosis related genes

Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients with Stage II Colorectal Cancer

Identification of disulfidptosis-associated genes and characterization of immune cell infiltration in thyroid carcinoma

Identification and validation of an immune-related gene signature predictive of overall survival in colon cancer

Identification of novel immune-related molecular subtypes and a prognosis model to predict thyroid cancer prognosis and drug resistance

Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation

Immune Gene Signature Delineates a Subclass of Thyroid Cancer with Unfavorable Clinical Outcomes.

Transcriptomic Signatures Associated with Autoimmune Thyroiditis in Papillary Thyroid Carcinoma and Cancer Immunotherapy-Induced Thyroid Dysfunction